Logo image of PRSO

PERASO INC (PRSO) Stock Fundamental Analysis

NASDAQ:PRSO - US71360T2006 - Common Stock

1.38 USD
+0.56 (+68.7%)
Last: 9/5/2025, 8:00:01 PM
1.23 USD
-0.15 (-10.87%)
After Hours: 9/5/2025, 8:00:01 PM
Fundamental Rating

3

Overall PRSO gets a fundamental rating of 3 out of 10. We evaluated PRSO against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. PRSO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PRSO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PRSO had negative earnings in the past year.
In the past year PRSO has reported a negative cash flow from operations.
PRSO had negative earnings in each of the past 5 years.
In the past 5 years PRSO always reported negative operating cash flow.
PRSO Yearly Net Income VS EBIT VS OCF VS FCFPRSO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

PRSO's Return On Assets of -118.82% is on the low side compared to the rest of the industry. PRSO is outperformed by 95.54% of its industry peers.
Looking at the Return On Equity, with a value of -220.02%, PRSO is doing worse than 91.07% of the companies in the same industry.
Industry RankSector Rank
ROA -118.82%
ROE -220.02%
ROIC N/A
ROA(3y)-149.9%
ROA(5y)-104.55%
ROE(3y)-311.07%
ROE(5y)-220.29%
ROIC(3y)N/A
ROIC(5y)N/A
PRSO Yearly ROA, ROE, ROICPRSO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

With a decent Gross Margin value of 56.06%, PRSO is doing good in the industry, outperforming 79.46% of the companies in the same industry.
PRSO's Gross Margin has declined in the last couple of years.
PRSO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.81%
GM growth 5Y-3.27%
PRSO Yearly Profit, Operating, Gross MarginsPRSO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

PRSO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PRSO has been increased compared to 1 year ago.
Compared to 5 years ago, PRSO has more shares outstanding
PRSO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRSO Yearly Shares OutstandingPRSO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
PRSO Yearly Total Debt VS Total AssetsPRSO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

PRSO has an Altman-Z score of -45.32. This is a bad value and indicates that PRSO is not financially healthy and even has some risk of bankruptcy.
PRSO's Altman-Z score of -45.32 is on the low side compared to the rest of the industry. PRSO is outperformed by 83.93% of its industry peers.
There is no outstanding debt for PRSO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -45.32
ROIC/WACCN/A
WACC11.31%
PRSO Yearly LT Debt VS Equity VS FCFPRSO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

PRSO has a Current Ratio of 2.03. This indicates that PRSO is financially healthy and has no problem in meeting its short term obligations.
PRSO has a Current ratio of 2.03. This is in the lower half of the industry: PRSO underperforms 71.43% of its industry peers.
A Quick Ratio of 1.48 indicates that PRSO should not have too much problems paying its short term obligations.
PRSO has a Quick ratio of 1.48. This is in the lower half of the industry: PRSO underperforms 72.32% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.48
PRSO Yearly Current Assets VS Current LiabilitesPRSO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.98% over the past year.
Looking at the last year, PRSO shows a small growth in Revenue. The Revenue has grown by 1.80% in the last year.
PRSO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.64% yearly.
EPS 1Y (TTM)92.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.18%
Revenue 1Y (TTM)1.8%
Revenue growth 3Y36.91%
Revenue growth 5Y7.64%
Sales Q2Q%-45.97%

3.2 Future

PRSO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.51% yearly.
PRSO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.63% yearly.
EPS Next Y61.17%
EPS Next 2Y35.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.18%
Revenue Next 2Y13.21%
Revenue Next 3Y7.63%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PRSO Yearly Revenue VS EstimatesPRSO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
PRSO Yearly EPS VS EstimatesPRSO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 0 -1K -2K -3K -4K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRSO. In the last year negative earnings were reported.
Also next year PRSO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRSO Price Earnings VS Forward Price EarningsPRSO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRSO Per share dataPRSO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as PRSO's earnings are expected to grow with 35.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.51%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PRSO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERASO INC

NASDAQ:PRSO (9/5/2025, 8:00:01 PM)

After market: 1.23 -0.15 (-10.87%)

1.38

+0.56 (+68.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners10.48%
Inst Owner Change109.74%
Ins Owners2.55%
Ins Owner Change0%
Market Cap8.51M
Analysts82.86
Price Target3.28 (137.68%)
Short Float %0.98%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.32%
Min EPS beat(2)39.67%
Max EPS beat(2)50.98%
EPS beat(4)3
Avg EPS beat(4)21.66%
Min EPS beat(4)-41.84%
Max EPS beat(4)50.98%
EPS beat(8)5
Avg EPS beat(8)-9.06%
EPS beat(12)8
Avg EPS beat(12)-0.72%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.53%
Min Revenue beat(2)-18.74%
Max Revenue beat(2)-0.31%
Revenue beat(4)0
Avg Revenue beat(4)-7.82%
Min Revenue beat(4)-18.74%
Max Revenue beat(4)-0.31%
Revenue beat(8)3
Avg Revenue beat(8)2.07%
Revenue beat(12)4
Avg Revenue beat(12)-4.11%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.91%
PT rev (3m)-1.91%
EPS NQ rev (1m)28.57%
EPS NQ rev (3m)46.81%
EPS NY rev (1m)24.2%
EPS NY rev (3m)28.45%
Revenue NQ rev (1m)-11.23%
Revenue NQ rev (3m)-2.82%
Revenue NY rev (1m)-10.86%
Revenue NY rev (3m)-13.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 2.85
P/tB 2.85
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS2.21
BVpS0.48
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -118.82%
ROE -220.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.06%
FCFM N/A
ROA(3y)-149.9%
ROA(5y)-104.55%
ROE(3y)-311.07%
ROE(5y)-220.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.81%
GM growth 5Y-3.27%
F-Score6
Asset Turnover2.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.48
Altman-Z -45.32
F-Score6
WACC11.31%
ROIC/WACCN/A
Cap/Depr(3y)11.82%
Cap/Depr(5y)21.25%
Cap/Sales(3y)2.49%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.18%
EPS Next Y61.17%
EPS Next 2Y35.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.8%
Revenue growth 3Y36.91%
Revenue growth 5Y7.64%
Sales Q2Q%-45.97%
Revenue Next Year-13.18%
Revenue Next 2Y13.21%
Revenue Next 3Y7.63%
Revenue Next 5YN/A
EBIT growth 1Y61.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.52%
OCF growth 3YN/A
OCF growth 5YN/A